Raav2-nd4    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
302Leber hereditary optic neuropathy2

302. Leber hereditary optic neuropathy    [ 20 clinical trials,   14 drugs,   (DrugBank: 4 drugs),   5 drug target genes,   32 drug target pathways]
Searched query = "Leber hereditary optic neuropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 20 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03153293
(ClinicalTrials.gov)
December 27, 201710/5/2017A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic NeuropathyA Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic NeuropathyLeber Hereditary Optic NeuropathyDrug: rAAV2-ND4Huazhong University of Science and TechnologyShiyan Taihe HospitalActive, not recruiting10 Years65 YearsAll159Phase 2;Phase 3China
2NCT01267422
(ClinicalTrials.gov)
April 201127/12/2010Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)Safety and Efficacy Study of a Single Intravitreal Injection of rAAV2-ND4 Treatment of Leber Hereditary Optic NeuropathyLeber Hereditary Optic NeuropathyDrug: rAAV2-ND4Bin LiHuazhong University of Science and TechnologyCompleted8 Years60 YearsAll9N/AChina